ImpactAlpha, May 1 – About 80% of the roughly three million newborn deaths in developing countries are preventable, according to the World Health Organization.
Neopenda’s wearable device monitors a newborn’s vital signs, including pulse rate, respiratory rate, blood oxygen saturation and temperature and alerts nurses and doctors if something is wrong.
The Chicago-based startup raised raised $1.04 million to manufacture and commercialize the product, and expand on its clinical pilot in Uganda. Seed financing came from New York-based Axel Johnson and East Africa-based venture firm Sunu Capital.
